Objective: The present work aim was “A solubility enhancement of aceclofenac by new crystallization technique.” Aceclofenac is non-steroidal anti-inflammatory drug comes under bio-pharmaceutics classification system Class II with low solubility and high permeability. The aim of the study was to study the solubility and dissolution rate of the pure drug and prepared crystals at different temperature. Methods: Crystal of aceclofenac was prepared by antisolvent sonocrystallization technique. Results: A different crystal was prepared by Antisolvent sonocrystallization technique. The effect of solvents, temperature, and sonication was investigated. All the formulation was studied the dissolution behavior, MDT, %DE, and solid state characterizati...
ABSTRACT: Aceclofenac is a novel non-steroidal anti-inflammatory drug (NSAID) having anti-inflammato...
Aim: The objective behind this study is to improve the compressibility, flowability, packability and...
In development of new product major constraints are poor aqueous solubility and low oral bioavailabi...
Reema Narayan,1 Abhyuday Pednekar,1 Dipshikha Bhuyan,1,2 Chaitra Gowda,1,3 KB Koteshwara,1 Usha Yoge...
Objective: The poor aqueous solubility of the drug exhibits in variable dissolution rate and hence p...
Aceclofenac agglomerates were prepared by spherical crystallization technique using a three solvent ...
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) having antiinflammatory and analgesic ...
Main objectives to develop Aceclofenac Nanosuspension are to enhance solubility and dissolution rate...
The nonsteroidal anti-inflammatory drug aceclofenac was screened with pharmaceutically acceptable co...
In this study the significant effect of chitosan on improving the dissolution rate and bioavailabili...
Objective: This study aims to synthesize acetylsalicylic acid (ASA) cocrystals using valine as a cof...
ABSTRACT Aceclofenac is a BCS (Bio-pharmaceutical classification system) class II drug which exhibit...
Purpose: To enhance the solubility and dissolution characteristics of ketoprofen using various cryst...
The objective of the present investigation was to study the effect of various water soluble carriers...
Aceclofenac (BSC class II drug) is a novel non-inflammatory drug (NSAID) having anti-inflammatory an...
ABSTRACT: Aceclofenac is a novel non-steroidal anti-inflammatory drug (NSAID) having anti-inflammato...
Aim: The objective behind this study is to improve the compressibility, flowability, packability and...
In development of new product major constraints are poor aqueous solubility and low oral bioavailabi...
Reema Narayan,1 Abhyuday Pednekar,1 Dipshikha Bhuyan,1,2 Chaitra Gowda,1,3 KB Koteshwara,1 Usha Yoge...
Objective: The poor aqueous solubility of the drug exhibits in variable dissolution rate and hence p...
Aceclofenac agglomerates were prepared by spherical crystallization technique using a three solvent ...
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) having antiinflammatory and analgesic ...
Main objectives to develop Aceclofenac Nanosuspension are to enhance solubility and dissolution rate...
The nonsteroidal anti-inflammatory drug aceclofenac was screened with pharmaceutically acceptable co...
In this study the significant effect of chitosan on improving the dissolution rate and bioavailabili...
Objective: This study aims to synthesize acetylsalicylic acid (ASA) cocrystals using valine as a cof...
ABSTRACT Aceclofenac is a BCS (Bio-pharmaceutical classification system) class II drug which exhibit...
Purpose: To enhance the solubility and dissolution characteristics of ketoprofen using various cryst...
The objective of the present investigation was to study the effect of various water soluble carriers...
Aceclofenac (BSC class II drug) is a novel non-inflammatory drug (NSAID) having anti-inflammatory an...
ABSTRACT: Aceclofenac is a novel non-steroidal anti-inflammatory drug (NSAID) having anti-inflammato...
Aim: The objective behind this study is to improve the compressibility, flowability, packability and...
In development of new product major constraints are poor aqueous solubility and low oral bioavailabi...